Mild Photothermal Stimulation Driven Nanoparticles Hybrid Dual‐Network Hydrogels for Bone Repair

Why It Matters

The platform simultaneously tackles vascularization and bone formation, two bottlenecks in regenerative orthopedics, offering a minimally invasive, tunable therapy for complex skeletal injuries.

Key Takeaways

• Dual-network hydrogel integrates GelMA, HA-DA, Fe3+ crosslinking
• Polydopamine nanoparticles enable mild photothermal stimulation
• Fe3+ ions promote angiogenesis and vascularization
• Photothermal group shows highest osteogenic gene expression
• In vivo defects exhibit superior bone formation with treatment

Pulse Analysis

Bone defects that exceed the body’s natural healing capacity demand biomaterials that can orchestrate both blood‑vessel growth and new bone formation. Traditional scaffolds often focus on one pathway, leading to incomplete regeneration and prolonged recovery. The PDA@GelMA/HA-DA/Fe3+ hydrogel leverages a dual‑network architecture, merging a covalently crosslinked GelMA matrix with ionically linked hyaluronic acid‑dopamine chains. This design yields a mechanically robust yet injectable gel, while the Fe3+ ions serve as endogenous angiogenic signals that stimulate endothelial cell migration and capillary sprouting within the defect site.

The inclusion of polydopamine (PDA) nanoparticles introduces a controllable photothermal element. Under mild near‑infrared irradiation, the PDA particles generate localized heat, which has been shown to up‑regulate osteogenic pathways such as Runx2, OCN, and ALP in mesenchymal stem cells. In vitro assays reveal that the combined hydrogel‑photothermal treatment outperforms the hydrogel alone, delivering higher alkaline phosphatase activity and mineral deposition. Mechanistically, the heat modestly increases membrane permeability and activates heat‑shock proteins, creating a favorable microenvironment for bone matrix synthesis without damaging surrounding tissues.

Animal studies using critical‑size calvarial defects confirm the translational promise of this approach. Micro‑CT and histology demonstrate dense, well‑vascularized bone tissue in the photothermal group, surpassing both blank and hydrogel‑only controls. For the orthopedic market, such a multifunctional material could reduce the need for autografts, lower infection risk, and accelerate patient rehabilitation. Future work may explore scalable manufacturing, integration with growth‑factor delivery, and clinical trials to validate safety and efficacy in human patients.